Year: 2017
Language: English
Author(s): World Federation of Hemophilia
At the WFH 2017 Global Forum in Montréal, David Page led a discussion between Alok Srivastava (India), Mark Skinner (USA), Margaret Ragni (USA), and Cedric Hermans (Belgium) to define the ideal clotting factor trough level for people with hemophilia, particularly in light of recent and ongoing advances in treatment options.
To learn more about factor trough levels in the context of novel therapies in the management of hemophilia, watch the other 2 videos of this panel discussion, Factor Trough Levels and Novel Hemophilia Therapies:
In this session from the WFH 2020 Virtual Summit, Glenn Pierce, Johnny Mahlangu, David Page & Brian O’Mahony explore the
In this session from the WFH 2020 Virtual Summit, Radoslaw Kaczmarek, Flora Peyvandi, Dan Hart & Johnny Mahlangu discuss novel
In this session from the WFH 2020 World Summit, Glenn Pierce will examine the evolution of gene therapy while addressing
Despite significant paradigm shifts in the medical management of hemophilia A with inhibitors and the expanding use of novel non-factor
This module was presented by Susan Cutter at the Virtual Workshop for Psychosocial Professionals in Central and South America on
In this session from the WFH 2020 Virtual Summit, Steve Kitchen, Emmanuel Favaloro, Robert Gosselin and Geoffrey Kershaw discuss: How